BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 35433958)

  • 1. Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy.
    Yang Y; Liu P; Teng R; Liu F; Zhang C; Lu X; Ding Y
    Ann Transl Med; 2022 Mar; 10(6):348. PubMed ID: 35433958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy.
    Liu Z; Song YN; Chen KY; Gao WL; Chen HJ; Liang GY
    World J Cardiol; 2022 May; 14(5):282-296. PubMed ID: 35702326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and identification of potential hub genes and immune cell infiltration in the synovial tissue of rheumatoid arthritis by bioinformatic approach.
    Feng ZW; Tang YC; Sheng XY; Wang SH; Wang YB; Liu ZC; Liu JM; Geng B; Xia YY
    Heliyon; 2023 Jan; 9(1):e12799. PubMed ID: 36699262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis.
    Zhu T; Wang M; Quan J; Du Z; Li Q; Xie Y; Lin M; Xu C; Xie Y
    Front Genet; 2022; 13():874544. PubMed ID: 35646094
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis.
    Gan T; Hu J; Aledan AKO; Liu W; Li C; Lu S; Wang Y; Xu Q; Wang Y; Wang Z
    Front Immunol; 2023; 14():1049351. PubMed ID: 36733486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy.
    Zhang H; Huo J; Jiang W; Shan Q
    Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
    Wang Z; Xia Q; Su W; Cao M; Sun Y; Zhang M; Chen W; Jiang T
    Front Cardiovasc Med; 2022; 9():824756. PubMed ID: 35282347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of miRNA-mRNA regulatory network and potential drugs in chronic chagasic cardiomyopathy across human and mouse.
    Wu J; Cao J; Fan Y; Li C; Hu X
    BMC Med Genomics; 2021 Nov; 14(1):283. PubMed ID: 34844599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel diagnostic biomarkers related to immune infiltration in Parkinson's disease by bioinformatics analysis.
    Zhang P; Zhao L; Li H; Shen J; Li H; Xing Y
    Front Neurosci; 2023; 17():1083928. PubMed ID: 36777638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the Key Genes of Immune Infiltration in Dilated Cardiomyopathy.
    Qi B; Wang HY; Ma X; Chi YF; Gui C
    Int Heart J; 2023 Nov; 64(6):1054-1064. PubMed ID: 37967988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy.
    Zhang Q; Fan M; Cao X; Geng H; Su Y; Wu C; Pan H; Pan M
    Front Cardiovasc Med; 2022; 9():809470. PubMed ID: 35433865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq.
    Fang C; Lv Z; Yu Z; Wang K; Xu C; Li Y; Wang Y
    BMC Cardiovasc Disord; 2022 Jul; 22(1):320. PubMed ID: 35850644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Immune Markers in Dilated Cardiomyopathies with Heart Failure by Integrated Weighted Gene Coexpression Network Analysis.
    Wang X; Guan H; Liu W; Li H; Ding J; Feng Y; Chen Z
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis.
    Peng C; Zhang Y; Lang X; Zhang Y
    J Transl Med; 2023 Feb; 21(1):66. PubMed ID: 36726122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of Dilated Cardiomyopathy-Related Genes via Bioinformatics Analysis.
    Wang LJ; Qiu BQ; Yuan MM; Zou HX; Gong CW; Huang H; Lai SQ; Liu JC
    Int J Gen Med; 2022; 15():3663-3676. PubMed ID: 35411175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of Immune-Related ceRNA Network in Dilated Cardiomyopathy: Based on Sex Differences.
    Liu C; Liu J; Wu D; Luo S; Li W; Chen L; Liu Z; Yu B
    Front Genet; 2022; 13():882324. PubMed ID: 35754849
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of cuproptosis-related genes and immune infiltration in dilated cardiomyopathy.
    Lin Y; Chen K; Guo J; Chen P; Qian ZR; Zhang T
    Int J Cardiol; 2024 Mar; 399():131702. PubMed ID: 38168558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of risk prediction and neural network models for dilated cardiomyopathy based on WGCNA.
    Yu W; Li L; Tan X; Liu X; Yin C; Cao J
    Front Med (Lausanne); 2023; 10():1239056. PubMed ID: 37869159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key immune-related genes in dilated cardiomyopathy using bioinformatics analysis.
    Li F; Du TY; Wu LD; Zhang L; Liu HH; Zhang ZY; Zhang J; Zhang ZY; Qian LL; Wang RX; Hao JF
    Sci Rep; 2023 Feb; 13(1):1820. PubMed ID: 36725968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the Immune Status of Hypertrophic Cardiomyopathy by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data.
    Zhao W; Wu T; Zhan J; Dong Z
    Comput Math Methods Med; 2022; 2022():7153491. PubMed ID: 36238494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.